RecruitingNCT04919538

Longitudinal Study for Relapsing Polychondritis


Sponsor

University of Pennsylvania

Enrollment

100 participants

Start Date

Feb 26, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Relapsing polychondritis (RP) is a rare systemic inflammatory disease characterized by recurrent inflammation of cartilage including ears, nose, tracheobronchial tree, chest wall and joints. Less commonly, it can cause inflammation of eyes, vasculature, nervous system, skin and inner ear. The purpose of this study is to study the pathogenesis of RP.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study is building a long-term registry of patients with relapsing polychondritis (RP) — a rare autoimmune disease that causes recurring inflammation of cartilage in the ears, nose, joints, airways, and other structures. Little is known about how this disease progresses over time, and this longitudinal study will track patients to improve understanding. You may be eligible if: - You have been diagnosed with relapsing polychondritis (as determined by your doctor) - You (or a guardian) can provide informed consent You may NOT be eligible if: - You are unable to provide consent and there is no guardian to provide assent on your behalf Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of Pennsylvania

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04919538


Related Trials